Home / Business and Economy / Goldman Sachs Accused of Fraud in Brazil Tender Offer Dispute
Goldman Sachs Accused of Fraud in Brazil Tender Offer Dispute
11 Aug
Summary
- Police accuse Goldman Sachs reps of fraud regarding Oncoclinicas shares.
- Allegations involve concealed ownership and improper share transfers.
- Minority shareholders claim deception and financial losses.
Sao Paulo civil police have formally accused two Goldman Sachs representatives of fraud. This accusation stems from a dispute over a public share tender offer involving minority shareholders of the cancer treatment group Oncoclinicas. The police documents suggest the executives concealed ownership details and executed share transfers without triggering a mandatory tender offer.
These actions allegedly deceived minority shareholders and caused them financial losses, violating statutory obligations. Goldman Sachs has responded by calling the allegations unfounded and maintaining that the bank acted appropriately. Oncoclinicas, the company at the center of the dispute, has declined to comment on the situation.
